The recognition of a role for GLP-1 in the pathophysiology of congenital and acquired hyperinsulinemic hypoglycemia has brought forward the possibility of targeting the GLP-1 receptor for the treatment of this condition and promising progress has been made to this end
There is generally no need to push the needle deeply or forcefully
Thats important as we focus on greater medication adherence and patient health outcomes across the country. Simplicity, transparency and reducing hurdles are key parts to why Humana executives, including company CEO Jim Rechtin, have said they began working on a partnership with Cost Plus Drugs in a unique arrangement between an established provider of health benefits to millions of Americans and a smaller disrupter co-funded by Cuban
The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones
Kirtley, who has lost 181 pounds, says her outlook on life has improved
Nonetheless, Mr Israetel says he doubts the findings of studies that suggest semaglutide causes muscle loss
